6.1Board of Directors compensation
The tables in this section are audited by the external auditor.
The following table shows the compensation for the individual Board members for the 2025/26 financial year (8 members from the 2025/26 AGM) and for the 2024/25 financial year (10 members). The total compensation in the 2025/26 financial year was CHF 2.8 million (2024/25: CHF 3.3 million).
Board of Directorsʼ compensation for the Financial Year
in CHF | 2025/26 | |||||||||
Cash retainer (fixed fee) | Total cash compensation | Grant value of restricted shares | Total compensation | Employer's social insurance contribution (AHV/ALV) 1 | ||||||
Gilbert Achermann 2 Board Chair/TIC Chair (since AGM 2025) | 365,833 | 365,833 | 369,914 | 735,747 | 45,510 | |||||
Robert F. Spoerry Board Chair (until AGM 2025) | 83,611 | 84,231 | 84,231 | 4,527 | ||||||
Stacy Enxing Seng Board Vice-Chair and NCC member (until AGM 2025) | 26,250 | 26,250 | 26,250 | 1,992 | ||||||
Gregory Behar NCC/TIC member | 128,056 | 128,056 | 159,894 | 287,950 | 18,646 | |||||
Lukas Braunschweiler NCC member (until AGM 2025) | 23,333 | 23,333 | 23,333 | 1,514 | ||||||
Roland Diggelmann NCC Chair | 140,000 | 140,000 | 159,894 | 299,894 | 19,421 | |||||
Lynn Dorsey Bleil AC/TIC member | 128,056 | 128,056 | 159,894 | 287,950 | 18,646 | |||||
Laura Stoltenberg TIC member (since AGM 2025) | 88,611 | 88,611 | 159,894 | 248,505 | 15,816 | |||||
Julie Tay NCC member | 120,000 | 120,000 | 159,894 | 279,894 | 18,088 | |||||
Ronald van der Vis AC member | 120,000 | 120,000 | 159,894 | 279,894 | 18,124 | |||||
Adrian Widmer AC Chair | 140,000 | 140,000 | 159,894 | 299,894 | 19,421 | |||||
Total | 1,363,750 | 1,364,370 | 1,489,172 | 2,853,542 | 181,705 | |||||
The compensation shown in the table above is gross and based on the accrual principle.
AC = Audit Committee; NCC = Nomination and Compensation Committee; TIC = Technology and Innovation Committee.
1Employer social security contributions on cash retainer. Restricted shares granted during the financial year.
2The Chairman of the Board also chairs the TIC. No separate or additional fees were provided for this function.
in CHF | 2024/25 | |||||||||
Cash retainer (fixed fee) | Total cash compensation | Grant value of restricted shares | Total compensation | Employer's social insurance contribution (AHV/ALV)1 | ||||||
Robert F. Spoerry 2 Board Chair | 430,000 | 430,000 | 369,953 | 799,953 | 44,588 | |||||
Stacy Enxing Seng3 Board Vice-Chair and NCC member | 135,000 | 135,000 | 159,919 | 294,919 | 18,448 | |||||
Gregory Behar AC member | 120,000 | 120,000 | 159,919 | 279,919 | 17,475 | |||||
Lynn Dorsey Bleil AC member | 120,000 | 120,000 | 159,919 | 279,919 | 17,475 | |||||
Lukas Braunschweiler NCC member | 120,000 | 120,000 | 159,919 | 279,919 | 348,913 | |||||
Roland Diggelmann NCC Chair | 140,000 | 140,000 | 159,919 | 299,919 | 18,773 | |||||
Julie Tay NCC member | 120,000 | 120,000 | 159,919 | 279,919 | 17,204 | |||||
Ronald van der Vis AC member | 120,000 | 120,000 | 159,919 | 279,919 | 17,475 | |||||
Adrian Widmer AC Chair | 140,000 | 140,000 | 159,919 | 299,919 | 18,773 | |||||
Gilbert Achermann Board member | 83,3333 | 83,3333 | 159,919 | 243,252 | 15,068 | |||||
Total | 1,528,333 | 1,528,333 | 1,809,224 | 3,337,557 | 534,192 | |||||
The compensation shown in the table above is gross and based on the accrual principle.
1Employer social security contributions on cash retainer, restricted shares granted during the financial year as well as stock options exercised during the financial year.
2Including NCC and AC work and attendance.
3Pro-rated for the period AGM 2024 to 31 March 2025.
6.1.1 Approved versus expected total compensation for the members of the Board of Directors
The total compensation paid to the full Board for the period from the 2025 AGM to the 2026 AGM is expected to be within the limits approved by the 2025 AGM.
Approved versus expected total compensation for the members of the Board of Directors
AGM approval year | 2024 | 2025 | ||||||
in CHF 1,000 | Approved for AGM 2024 - AGM 2025 | Effective for AGM 2024 - AGM 2025 | Approved for AGM 2025 - AGM 2026 | Expected for AGM 2025 - AGM 2026 | ||||
Total compensation | 3,500 | 3,194 | 3,050 | 2,809 | ||||
Breakdown total compensation: | ||||||||
Fixed fees including expenses | 1,610 | 1,545 | 1,480 | 1,320 | ||||
Grant value of restricted shares | 1,890 | 1,649 | 1,570 | 1,489 | ||||
Number of members of the Board of Directors | 10 | 10 | 8 | 8 | ||||
6.1.2 Other compensation, loans, and credit for current and former members of the Board of Directors and related parties
Additional compensation: No other compensation was paid to current or former Board members for services beyond the total compensation disclosed above.
Related party payments: No payments were made to individuals closely related to any current or former Board members during the reporting year.
Loans and credit: Neither Sonova nor any Group company granted loans to current or former Board members in the 2025/26 financial year, and no such loans were outstanding as of 31 March, 2026. Similarly, no loans were granted to related parties of current or former Board members.
6.1.3 Outside mandates
As of 31 March 2026, the Board members held the following mandates outside Sonova:
2025/26 | ||||||||
Listed companies | Function | Other mandates | Function | |||||
Gilbert Achermann | Ypsomed Group | Board Chair | Unilabs Group | Board Chair | ||||
Greenteg | Board member | |||||||
IMD Lausanne | Supervisory Board of IMD member | |||||||
Swiss Medtech Association | Member of the Management Board and Vice President | |||||||
Gregory Behar | n.a. | n.a. | Recipharm AB | CEO | ||||
Amazentis SA | Board member | |||||||
New Biologix | Board member | |||||||
Lynn Dorsey Bleil | Alcon Inc. | Board member | Intermountain Healthcare Wasatch Back Hospitals Community Board | Board Chair | ||||
Amicus Therapeutics Inc. | Board member | |||||||
Roland Diggelmann | Mettler Toledo International Inc. | Board Chair | Berlin Heals AG | Board member | ||||
HeartForce AG | Board member | |||||||
Navignostics AG | Board member | |||||||
Osler Diagnostics Ltd. | Board member | |||||||
Laura Stoltenberg | n.a. | n.a. | Cryosa | President and CEO | ||||
Julie Tay | EBOS Group Ltd. | Board member | n.a. | n.a. | ||||
Ronald van der Vis | n.a. | n.a. | Industry Advisor | Operating Partner, Co-Investor | ||||
European Dental Group | Supervisory Board Chair | |||||||
Equipe Zorgbedrijven | Supervisory Board Chair | |||||||
HEMA BV | Supervisory Board Chair | |||||||
Adrian Widmer | Sika AG | Group CFO | n.a. | n.a. |
2024/25 | ||||||||
Listed companies | Function | Other mandates | Function | |||||
Robert F. Spoerry | Bystronic Holding AG | Member of the Board of Directors | n.a. | n.a. | ||||
Stacy Enxing Seng | LivaNova Inc. | Member of the Board of Directors | Cala Health | Chair of the Board of Directors | ||||
Contego Inc. | Executive Chair of the Board of Directors | |||||||
Corza Inc. | Member of the Board of Directors | |||||||
Imperative Care | Member of the Board of Directors | |||||||
Lightstone Ventures | Operating Partner | |||||||
Gregory Behar | n.a. | n.a. | Recipharm AB | CEO | ||||
Amazentis SA | Member of the Board of Directors | |||||||
New Biologix | Member of the Board of Directors | |||||||
Lynn Dorsey Bleil | Alcon Inc. | Member of the Board of Directors | Intermountain Healthcare Wasatch Back Hospitals Community Board | Chair | ||||
Amicus Therapeutics Inc. | Member of the Board of Directors | |||||||
Lukas Braunschweiler | Tecan Group AG | Chair of the Board of Directors | n.a. | n.a. | ||||
Roland Diggelmann | Mettler Toledo International Inc. | Chair of the Board of Directors | Berlin Heals AG | Member of the Board of Directors | ||||
HeartForce AG | Member of the Board of Directors | |||||||
Navignostics AG | Member of the Board of Directors | |||||||
Osler Diagnostics Ltd. | Member of the Board of Directors | |||||||
Julie Tay | EBOS Group Ltd. | Member of the Board of Directors | n.a. | n.a. | ||||
Ronald van der Vis | n.a. | n.a. | Industry Advisor | Operating Partner, Co-Investor | ||||
European Dental Group | Chair of the Supervisory Board | |||||||
Equipe Zorgbedrijven | Chair of the Supervisory Board | |||||||
United Veterinary Care | Chair of the Supervisory Board | |||||||
HEMA BV | Member of the Supervisory Board | |||||||
Adrian Widmer | Sika AG | Group CFO | n.a. | n.a. | ||||
Gilbert Achermann | Ypsomed Group | Member of the Board of Directors | Unilabs Group | Chair of the Board of Directors | ||||
Greentech | Member of the Board of Directors | |||||||
IMD Lausanne | Vice Chair of the Supervisory Board | |||||||
SwissMedtech Association | Vice Chair |